CRO directory 2026

    Clinical Research Organizations in the UAE

    A clinical study in the United Arab Emirates is an emirate-by-emirate exercise: Dubai Health Authority, the Department of Health – Abu Dhabi, the Ministry of Health and Prevention and Dubai Healthcare City Authority each hold a piece of ethics and permission, while the monitors who make visits usually sit in Dubai Healthcare City or Abu Dhabi.

    Global CROs — IQVIA, ICON, Parexel, PPD (Thermo Fisher), Fortrea and Syneos — run Gulf programmes from UAE desks and treat Cleveland Clinic Abu Dhabi, SEHA tertiary hospitals, Dubai Health teaching sites and a handful of private groups as the enrolment engines. ClinArt MENA, founded in Dubai Healthcare City and later bought by CTI Clinical Trial and Consulting, is the regional house that still appears when a mid-sized sponsor wants one contract across the Gulf and Egypt. MCT-CRO covers the Emirates from a Maghreb-anchored network. Hospital research offices at Cleveland Clinic Abu Dhabi, PureHealth/SEHA, Dubai Health / MBRU and Thumbay University Hospital negotiate budgets and IRBs. Foreign sponsors usually file through a Dubai- or Abu Dhabi-licensed agent, so ClinArt/CTI and the global desks still pick up paperwork-only mandates. This directory sets out who monitors, who hosts patients, who signs the ethics letter and which emirate owns the file.

    Updated September 2026 · Dubai Health Authority — research permissions and licensed facilities (with DoH Abu Dhabi and DHCR as sister regimes) as of September 2026 · 17 named accounts

    Request a proposal for the UAEBrowse the 17 companies

    4

    Research-permission regimes a multi-emirate protocol can touch (DoH, DHA, MOHAP, DHCR)

    1

    Premium quaternary site most often named on complex industry protocols (Cleveland Clinic Abu Dhabi)

    2001

    Year ClinArt opened in Dubai Healthcare City, still the regional CRO address sponsors quote

    ~9m

    Residents on mandatory health insurance in Dubai and Abu Dhabi, the insured pool behind many observational studies

    Named accounts

    Top clinical research organizations (CROs) in the UAE

    Public, well-known names BioNixus studies at account and SKU level. This is an editorial snapshot, not an endorsement or a market-share ranking. Cross-checked against Dubai Health Authority — research permissions and licensed facilities (with DoH Abu Dhabi and DHCR as sister regimes) (as of 2026-09-04).
    #CompanyHQ
    01IQVIA — UAEDubai
    02ICON plc — UAEDubai
    03Parexel — UAEDubai
    04PPD, part of Thermo Fisher ScientificDubai
    05FortreaDubai
    06Syneos Health — UAEDubai
    07ClinArt MENA (CTI Clinical Trial and Consulting)Dubai
    08MCT-CROTunis
    09Department of Health – Abu Dhabi — researchAbu Dhabi
    10Dubai Health Authority — research officeDubai
    11Dubai Healthcare City Authority – Regulatory (DHCR)Dubai
    12Ministry of Health and Prevention — researchDubai
    13Cleveland Clinic Abu Dhabi — research officeAbu Dhabi
    14PureHealth / SEHA — academic and research units (AHS legacy)Abu Dhabi
    15Dubai Health / Mohammed Bin Rashid UniversityDubai
    16Thumbay University Hospital — researchAjman
    17Mediclinic Middle East — research officeDubai

    Primary research

    These are the clinical research partners we benchmark in the UAE

    Selecting sites or a CRO in the UAE? BioNixus runs investigator and site-feasibility interviews, patient-pathway mapping and competitor-trial landscaping. Proposal within 48 hours.

    Planning research in United Arab Emirates?

    Primary research, market access & HEOR. Proposals within 48 hours.

    Top market research companies in the UAE (2026)

    How the market is structured

    How a trial is approved and staffed across the seven emirates

    Start with the emirate, not with the CRO logo. An Abu Dhabi interventional study needs DoH research approval and an IRB at the participating SEHA, M42 or Cleveland Clinic site. A Dubai hospital study needs DHA permission, or a DHCR research permit if the work sits inside Dubai Healthcare City. Northern-emirate sites pull in MOHAP. Multi-emirate programmes therefore stack ethics clocks. The sponsor or its CRO then contracts the hospital research office — Cleveland Clinic Abu Dhabi is the most professionalised private-quaternary office; Dubai Health / MBRU and PureHealth/SEHA handle academic and public volume; Mediclinic, Burjeel and Thumbay are smaller but usable. Global CROs supply monitors, data and central-lab routes; samples often leave through Dubai. ClinArt / CTI and MCT-CRO take the mid-sized and multi-country MENA briefs that a global firm will not staff locally. Insurance is not the ethics gate, but Thiqa and Dubai Essential Benefits data, plus Malaffi and NABIDH, make retrospective and registry work unusually tractable once the permit is in hand. Feasibility that ignores emirate jurisdiction produces a pretty spreadsheet and a stalled first-patient date.

    Local

    UAE-staffed regional operations and free-zone CROs; the domestic legal-representative role is usually played by ClinArt/CTI or by a global firm’s Dubai entity rather than by a purely Emirati boutique.

    Multinational

    IQVIA, ICON, Parexel, PPD, Fortrea and Syneos desks that deliver UAE sites inside global programmes, plus Cleveland Clinic and Mediclinic as international-brand sites.

    • IQVIA — UAE
    • ICON plc — UAE
    • Parexel — UAE
    • PPD, part of Thermo Fisher Scientific
    • Fortrea
    • Syneos Health — UAE
    • Cleveland Clinic Abu Dhabi — research office
    • Mediclinic Middle East — research office

    Regional

    ClinArt MENA under CTI and MCT-CRO, the two regional contracts that still bundle the Emirates with Egypt, the Levant and the Maghreb.

    • ClinArt MENA (CTI Clinical Trial and Consulting)
    • MCT-CRO

    Sites, SMOs & regulators

    DoH, DHA, DHCR and MOHAP as permission regimes, with PureHealth/SEHA, Dubai Health/MBRU and Thumbay as the hospital research offices that enrol.

    • Department of Health – Abu Dhabi — research
    • Dubai Health Authority — research office
    • Dubai Healthcare City Authority – Regulatory (DHCR)
    • Ministry of Health and Prevention — research
    • PureHealth / SEHA — academic and research units (AHS legacy)
    • Dubai Health / Mohammed Bin Rashid University
    • Thumbay University Hospital — research

    What is moving

    What is moving clinical research in the UAE

    Professionalised quaternary and academic offices

    Cleveland Clinic Abu Dhabi, MBRU and SEHA research units now negotiate like European sites, which is why global protocols keep adding an UAE row.

    Genomics and ATMP ambition in Abu Dhabi

    M42’s cohort and DoH advanced-therapy rules pull first-in-region gene and cell studies into Abu Dhabi, creating specialist CRO and site demand.

    Insured, multi-ethnic catchment

    Mandatory cover plus a resident mix that spans South Asia, the Levant, Europe and the Gulf makes observational and some interventional enrolment faster than in thinner neighbours.

    Free-zone research permits

    DHCR’s Approved Research Operator path lets a CRO or sponsor entity live next to the hospital inside Dubai Healthcare City, which shortens some start-up loops.

    BioNixus fieldwork

    How BioNixus studies clinical research organizations (CROs) in the UAE

    The accounts above are the ones our field teams and analysts work with. What a brand team typically commissions from us in the UAE:
    • Start-up clock mapping in Dubai and Abu Dhabi that separates DHA, DHCR and DoH steps on recent interventional submissions.
    • Investigator and study-coordinator interviews at Cleveland Clinic Abu Dhabi, Sheikh Shakhbout and Dubai Health hospitals on monitor quality and query speed.
    • Feasibility surveys estimating eligible pools for oncology and cardiometabolic protocols across Abu Dhabi, Dubai and Ajman.
    • Sponsor medical-director interviews on why they pick ClinArt/CTI versus a global CRO desk for a multi-country MENA add-on.

    Clinical Research Organizations market research in the UAE

    Questions

    Frequently Asked Questions

    Does a foreign sponsor need a UAE legal presence to run a trial?

    A locally accountable representative is expected. Global CROs with a Dubai entity, ClinArt/CTI, or another licensed organisation typically file, hold correspondence and remain visible to the emirate regulator.

    Which ethics body do I use?

    The one that owns the site. DoH and the hospital IRB for Abu Dhabi. DHA or DHCR for Dubai, depending on whether the work is inside Healthcare City. MOHAP for many northern-emirate sites. Multi-emirate protocols stack those clocks.

    Which sites enrol the most industry patients?

    Cleveland Clinic Abu Dhabi for complexity; SEHA tertiary hospitals for public volume; Dubai Health teaching hospitals for Dubai public-academic work; Mediclinic, Burjeel and Thumbay as smaller private options.

    Is ClinArt still independent?

    CTI bought it in 2020. Sponsors still meet the Dubai Healthcare City team under the ClinArt MENA name. Treat it as a CTI regional node, not as a vanished brand.

    What fieldwork does BioNixus run on UAE trial vendors and sites?

    Investigator and coordinator interviews at Cleveland Clinic Abu Dhabi, SEHA and Dubai Health sites; start-up clock mapping across DoH, DHA and DHCR; and sponsor interviews on CRA quality and payment speed.

    Is this directory a ranking of CROs operating in the UAE?

    It is a jurisdiction-and-role map. Organisations appear because they recur in BioNixus UAE site-feasibility work and on DoH, DHA and DHCR permit lists. Order follows function, not billings.

    Sources

    Data sources & methodology

    This directory aggregates publicly available company and channel facts — filings, brand sites, and BioNixus fieldwork in the UAE. It is an editorial snapshot of the accounts we study, not a share ranking and not a substitute for NielsenIQ, IQVIA, or another syndicated feed.

    Primary register: Dubai Health Authority — research permissions and licensed facilities (with DoH Abu Dhabi and DHCR as sister regimes), consulted 2026-09-04. Company classification (Local / MNC / Regional / sites, smos & regulators) reflects ownership and role in the UAE, not size.

    • Dubai Health Authority, Department of Health – Abu Dhabi and DHCR research-permit materials
    • CTI announcement of the ClinArt acquisition, 2020; company sites of IQVIA, ICON, Parexel, PPD, Fortrea and Syneos
    • Cleveland Clinic Abu Dhabi, Dubai Health / MBRU and PureHealth research-office descriptions
    • BioNixus UAE site-feasibility, investigator and sponsor fieldwork, 2023–2026

    BioNixus sells account-level and SKU-level primary research that complements those subscriptions. For a scoped proposal, contact the team or use the form below. Email admin@bionixus.com.

    48-hour proposal

    Need site and investigator intelligence in the UAE?

    Feasibility, recruitment realism and investigator preference — from the sites, not the sponsor deck.

    Planning research in United Arab Emirates?

    Primary research, market access & HEOR. Proposals within 48 hours.